Video·3 min read·May 2026

Finding Relief: The Impact of Whole-Body Cryotherapy on Joint Pain for Breast Cancer Patients

Cold Therapy • 3 min read • Based on research by Martha Duraes, Marion Garbay, Catherine Ferrer, Claire Duflos, Gauthier Rathat (2023)

For many women navigating the challenges of early-stage breast cancer, the journey doesn’t end with treatment. Aromatase inhibitors, often prescribed as part of hormone therapy, can bring relief from cancer but may also introduce a new set of challenges. Joint pain, affecting up to 50% of patients, can significantly impact quality of life, making it difficult to maintain daily activities and overall well-being.

Emerging research offers a glimmer of hope. A recent clinical trial explored the effects of whole-body cryotherapy (WBC) on joint pain caused by aromatase inhibitors. This study not only sheds light on a potential pathway to relief but also emphasizes the importance of holistic approaches to wellness in the face of medical treatments.

Understanding Whole-Body Cryotherapy

Whole-body cryotherapy involves exposing the body to extremely cold temperatures for a short duration, typically around three minutes. This process stimulates physiological responses that can reduce inflammation and pain. The study conducted by Duraes et al. was significant as it was the first to assess a standardized WBC protocol specifically for women experiencing joint pain from aromatase inhibitors.

In the trial, 56 participants received either WBC or placebo cryotherapy over ten sessions. The goal was to evaluate the effectiveness of WBC in alleviating pain and improving quality of life, particularly in those grappling with the side effects of hormone therapy.

Key Findings and Their Implications

The results from this randomized, placebo-controlled trial indicated that WBC may indeed reduce joint pain associated with aromatase inhibitors. Participants who underwent WBC reported improvements in their pain levels, leading to a decrease in the need for analgesics and enhancing their overall quality of life.

This finding is particularly important as managing joint pain effectively can help patients adhere to their treatment protocols, reducing the risk of discontinuation of essential hormone therapies. By integrating WBC into their recovery rituals, patients may find a pathway to maintaining their treatment plans while enhancing their well-being.

The Path Forward: Integrating Cryotherapy into Wellness Protocols

As this research unfolds, it signals a shift toward incorporating innovative therapies into standard pain management practices for breast cancer patients. Whole-body cryotherapy stands out as a viable alternative, offering a non-invasive method for alleviating discomfort.

For those interested in exploring WBC, it is essential to approach this therapy as part of a comprehensive wellness protocol. Engaging with qualified practitioners and considering individual health needs will ensure a safe and beneficial experience. As research continues to validate these findings, WBC may become a staple in the toolkit for enhancing resilience and quality of life for many.

Key Takeaways

Whole-body cryotherapy may provide relief from joint pain caused by aromatase inhibitors in breast cancer patients.
Integrating WBC into wellness protocols can enhance quality of life and support adherence to hormone therapy.

Based on: Effect of whole-body cryotherapy versus placebo cryotherapy on joint pain induced by aromatase inhibitors in women with early stage breast cancer: a randomised clinical trial
Martha Duraes, Marion Garbay, Catherine Ferrer, Claire Duflos, Gauthier Rathat (2023). BMJ Open

Contrast Collective • Science-backed wellness

Wim's Wise Words

A second take, from someone who's lived it.

🧊 Wim's Wise Words

Effect of whole-body cryotherapy versus placebo cryotherapy on joint

The Core Claim

This paper isn't reporting results — it's registering a trial that hadn't yet run when it was published. Duraes and her team at Montpellier University Hospital designed the first standardized whole-body cryotherapy protocol specifically for a precise clinical problem: the joint pain that drives so many breast cancer patients off their aromatase inhibitors before treatment is complete.

That framing matters. Aromatase inhibitors are among the most effective adjuvant therapies we have for hormone-receptor-positive breast cancer. But up to 50% of patients develop significant arthralgia — and somewhere between 13% and 50% discontinue treatment within three years because of it. The cancer therapy works. The side effect undermines the therapy. Duraes is asking whether cryotherapy can close that gap.

What the Research Landscape Says

Whole-body cryotherapy has an established track record in rheumatoid arthritis and ankylosing spondylitis. Gizinska et al. showed pain reduction and interleukin-6 suppression in 25 rheumatoid arthritis patients. Jastrzabek found similar results with 20 sessions at minus 160 degrees Celsius. Stanek demonstrated that pairing cryotherapy with physical therapy outperformed physical therapy alone in ankylosing spondylitis patients.

The mechanistic picture is consistent: cold exposure triggers vasoconstriction, suppresses pro-inflammatory cytokines, boosts anti-inflammatory ones, and activates antioxidative pathways. These aren't mysterious effects — they're the same physiological levers that researchers have documented across dozens of cold exposure studies. The question Duraes is asking is whether the same mechanism that quiets rheumatoid joint inflammation also quiets the specific inflammation pattern that aromatase inhibitors create.

The cancer therapy works. The side effect undermines the therapy. The question is whether cold can close that gap — and the mechanism suggests it can.

Where the Field Agrees and Disagrees

There's genuine consensus that WBC reduces inflammatory markers. Where experts diverge is on protocol design: how cold, how long, how often. The French National Institute of Health and Medical Research flagged this exact problem in 2019 — most cryotherapy studies used different temperatures, different durations, different session counts, making it nearly impossible to compare findings or issue clinical recommendations. Duraes is building the standardized protocol the field has been missing.

The placebo problem is also worth naming. The paper acknowledges it directly: placebo cryotherapy may produce larger effects than pharmacological placebos. When you put someone in what looks like a cryotherapy chamber, the expectation of benefit is powerful. A rigorous double-blind design is the only way to separate genuine biological effect from expectation, and this trial was designed to do exactly that.

The Practical Take

If you or someone you care about is navigating aromatase inhibitor therapy and experiencing joint pain, this research suggests cryotherapy is worth exploring — with your oncologist's involvement. The safety profile of WBC is well-documented, the mechanism is sound, and the preliminary evidence from adjacent conditions is encouraging. Ten sessions is a modest commitment. The alternative — discontinuing a therapy that may be keeping cancer from returning — is not a modest trade-off.

The Surprising Connection

What strikes me about this study is what it represents for cryotherapy as a field. For years, cold exposure has lived in two worlds: elite athletic recovery and biohacker wellness culture. Neither world required the rigorous double-blind, randomized, placebo-controlled methodology that clinical medicine demands. This trial is different. It's asking cryotherapy to earn its place in an oncology protocol — to prove itself by the same standards as a pharmaceutical drug. That's a significant moment. If the results hold, it doesn't just help breast cancer patients. It establishes a template for evaluating cold therapy in clinical contexts that wellness culture never demanded. That legitimacy changes everything about how the medical establishment will approach this modality going forward.

Effect of whole-body cryotherapy versus placebo cryotherapy on joint

Finding Relief: The Impact of Whole-Body Cryotherapy on Joint Pain for Breast Cancer Patients

Understanding Whole-Body Cryotherapy

Key Findings and Their Implications

The Path Forward: Integrating Cryotherapy into Wellness Protocols

Key Takeaways

Related articles

Effect of whole body cryotherapy on low back pain and release of endorphins and stress hormones in patients with lumbar spine osteoarthritis

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral

Use of Cryotherapy for Managing Chronic Pain An Evidence-Based Narrative